Sentences with phrase «life science companies across»

The Redefining Early Stage Investments (RESI) Conference is an ongoing conference series that provides an international venue for early stage life science companies across Biotech, Medtech, Diagnostics and Healthcare IT and to source investors from around the globe, create relationships, and eventually, secure funding.

Early Stage Investors and Strategic Partners Matched with Fundraising CEOs and Scientist - Entrepreneurs The Redefining Early Stage Investments (RESI) Conference is an ongoing conference series that provides an international venue for early stage life science companies across Biotech, Medtech, Diagnostics and Healthcare IT and to source investors from around the globe, create relationships, and eventually, secure funding.

Not exact matches

Astia Angels, a global network of angel investors, backs select Astia companies across the sectors of tech, life science, med device, consumer products and health and wellness.

Anne has held the finance function for various companies in the life sciences and health care industry across Europe.

Although the freeze - drying science and technology used by the company is similar across other freeze - drying plants, Freeze - Dry Foods stands out from its competitors by living its values of customer service, dependability, teamwork and integrity every day.

With investments in more than 200 companies across 15 countries, Tavistock Group's investment portfolio includes: life sciences, sports teams and sporting events, manufacturing and distribution, oil, gas and energy, financial services, restaurants, commercial properties, private luxury residential properties, resort properties and master - planned real estate developments.

Across the broad range of life science research under way in biotechnology and pharmaceuticals, many companies need scientists with traditional skills, such as pharmacology or biology.

«London can now start to compete more effectively with other municipalities and across borders to attract leading - edge life sciences companies.»

While fewer students are choosing to take chemistry Ph.D. s across the US according to a recent news article in Science (6 April 2007, p. 35), life science companies are crying out for postgraduate chScience (6 April 2007, p. 35), life science companies are crying out for postgraduate chscience companies are crying out for postgraduate chemists.

A # 14 million, five - year partnership between the BBSRC, the Engineering and Physical Science Research Council and a consortium of leading companies such as GlaxoSmithKline and Pall Life Sciences, it aims to fund innovative biotechnology - related research across several universities.

TCG's investment strategy runs counter to the prevailing trend in life sciences venture capital toward assembling diversified portfolios of later stage, single product - orientated companies across multiple industry sectors, with proximity to value inflection points and the early identification of a Pharma «buyer» as key investment considerations.

Films that might have fit this putative strand included the charming but overlong Timeless Stories, co-written and directed by Vasilis Raisis (and winner of the Michael Cacoyannis Award for Best Greek Film), a story that follows a couple (played by different actors at different stages of the characters» lives) across the temporal loop of their will - they, won't - they relationship from childhood to middle age and back again — essentially Julio Medem - lite, or Looper rewritten by Richard Curtis; Michalis Giagkounidis's 4 Days, where the young antiheroine watches reruns of Friends, works in an underpatronized café, freaks out her hairy stalker by coming on to him, takes photographs and molests invalids as a means of staving off millennial ennui, and causes ripples in the temporal fold, but the film is as dead as she is, so you hardly notice; Bob Byington's Infinity Baby, which may be a «science - fiction comedy» about a company providing foster parents with infants who never grow up, but is essentially the same kind of lame, unambitious, conformist indie comedy that has characterized U.S. independent cinema for way too long — static, meticulously framed shots in pretentious black and white, amoral yet supposedly lovable characters played deadpan by the usual suspects (Kieran Culkin, Nick Offerman, Megan Mullally, Kevin Corrigan), reciting apparently nihilistic but essentially soft - center dialogue, jangly indie music at the end, and a pretty good, if belated, Dick Cheney joke; and Petter Lennstrand's loveably lo - fi Up in the Sky, shown in the Youth Screen section, about a young girl abandoned by overworked parents at a sinister recycling plant, who is reluctantly adopted by a reconstituted family of misfits and marginalized (mostly puppets) who are secretly building a rocket — it's for anyone who has ever loved the Tintin moon adventures, books with resourceful heroines, narratives with oddball gangs, and the legendary episode of Angel where David Boreanaz turned into a Muppet.

Clients include multinational companies, state - owned enterprises and sovereign wealth funds active across a range of sectors, including shipping, pharmaceuticals, healthcare and life sciences, consumer goods, food and beverages, mining and IT.

I help clients in the life sciences, technology, and media industries develop and execute IP strategies to serve their business objectives across the spectrum from bet - the - company litigation to transactional due diligence to research and development.

We have experience providing comprehensive, practical and creative solutions to Fortune 500 companies, multinationals and start - ups, as well as entrepreneurs and high - net - worth individuals across a wide range of industries, including marketing and advertising services, life sciences, financial services, healthcare, technology, manufacturing and retail.

She has more than a dozen years of experience representing leading technology and life sciences companies in high stakes patent infringement, trade secret, and breach of contract litigation in federal courts across the country.

He has a wealth of experience and deep knowledge representing Chinese companies and Chinese government agencies in US regulatory compliance matters and litigation across a number of industry sectors including pharmaceutical, life sciences, manufacturing and retail.

As smaller companies, life science startups often require their people to engage in contact across both the business and scientific communities.

They have offices across the globe (e.g. Dublin, UK, Switzerland, Berlin, San Diego, Tokyo, Sydney) and recruit for technical / engineering / software skills for clients including technology companies, clinical research organisations, educational establishments, health services, pharmaceutical, biotechnology and life sciences companies.

We represent companies that range in size from small technology start - ups to Fortune 1000 companies across a wide spectrum of industries, including software, life sciences, medical devices, professional services, financial services, construction, manufacturing, retail, non-profit and healthcare.